1. Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol. Issue 6 (20th February 2021) Authors: Stutterheim, Janine; van der Sluis, Inge M.; de Lorenzo, Paola; Alten, Julia; Ancliffe, Philip; Attarbaschi, Andishe; Brethon, Benoit; Biondi, Andrea; Campbell, Myriam; Cazzaniga, Giovanni; Escherich, Gabriele; Ferster, Alina; Kotecha, Rishi S.; Lausen, Birgitte; Li, Chi Kong; Lo Nigro, Luca; Loc... Journal: Journal of clinical oncology Issue: Volume 39:Issue 6(2021) Page Start: 652 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Infant T‐cell acute lymphoblastic leukaemia with t(6;7) (TCRB‐MYB) translocation. (1st July 2021) Authors: Ramdeny, Pemantah Sandheeah; Mullanfroze, Khushnuma; de Lorenzo, Paola; Grazia Valsecchi, Maria; Meijerink, Jules; Pieters, Rob; Baruchel, Andre; Vora, Ajay Journal: British journal of haematology Issue: Volume 194:Number 3(2021) Page Start: 613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia. (April 2016) Authors: Driessen, Emma M.C.; Pinhanços, Sandra S. Mimoso; Schneider, Pauline; de Lorenzo, Paola; Valsecchi, Maria G.; Pieters, Rob; Stam, Ronald W. Journal: European journal of cancer Issue: Volume 57(2016) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗